Some Angiotensin Receptor Blockers More Potent Than Others
Different angiotensin receptor blockers have distinct potencies for suppressing adrenal β-arrestin1-dependent post-myocardial infarction hyperaldosteronism, according to a letter published in the Dec. 30 issue of the Journal of the American College of ...
Doctors Lounge - Mon, 09 Feb 2015 09:37

Electrolytes in cardiology
Hypokalaemia can also be due to increased loss of potassium through renal excretion, which may be caused by diabetes insipidus, hypercalcaemia, hyperaldosteronism, excessive fluid replacement therapy and diarrhoea. A typical ECG for a patient with ...
The Pharmaceutical Journal - Tue, 03 Feb 2015 09:43

Researcher Discovers Certain ARB Drugs Are More Effective Than Others at ...
25, 2014) in an article titled “Different Potencies of Angiotensin Receptor Blockers at Suppressing Adrenal β-Arrestin1-Dependent Post-Myocardial Infarction Hyperaldosteronism.” Results of the study are also published in Scientific Reports (Vol. 5, Jan.
Newswise (press release) - Mon, 02 Feb 2015 13:11

Expert examines contribution of aldosterone in obesity-related hypertension
Majewski also stressed that obesity-related hyperaldosteronism is different than true primary hyperaldosteronism. Guidelines from The Endocrine Society recommend that screening for primary hyperaldosteronism occur in patients with hypertension and ...
Healio - Fri, 24 Oct 2014 13:09

Endocrine system diseases
Consider hyperaldosteronism Subscription. By Nadhia Bashir, Scott Akker, Hasanin Khachi. It is estimated that primary hyperaldosteronism is the cause of hypertension in as much as 5 per cent of patients. This article focuses of the two most common ...
The Pharmaceutical Journal - Mon, 01 Dec 2014 10:13

GSK announces 14 winners of Discovery Fast Track Challenge
Morris Brown, University of Cambridge (UK): Primary hyperaldosteronism; Dr. Federica Briani, Università degli Studi di Milano (Italy): Targeting bacterial infections; Dr. Christos Chatziantoniou, National Institute of Health and Medical Research ...
MedCity News - Mon, 01 Dec 2014 03:48

GSK names drug hunter challenge winners
PMLiVE - Tue, 02 Dec 2014 02:41

Winners of GSK Discovery Fast Track Challenge Announced
Genetic Engineering & Biotechnology News - Mon, 01 Dec 2014 11:07

Cambridge dominates GSK medical discovery challenge
Business Weekly - Wed, 03 Dec 2014 01:45

Estrogen May Protect Heart by Inhibiting Mineralocorticoid
Several anti-mineralocorticoid diuretics have been approved and are used to treat chronic heart failure, hypertension and a condition known as hyperaldosteronism. "These drugs act on the mineralocorticoid receptor in the kidneys to lower blood pressure ...
MedPage Today - Sun, 09 Nov 2014 12:05

Severe Sleep Apnea Linked to Resistant Hypertension
Severe obstructive sleep apnea may interfere with blood pressure (BP)–lowering treatment in patients at high cardiovascular disease risk or with established cardiovascular disease, results of a multicenter clinical trial suggest. Doctors should ...
Medscape - Thu, 02 Oct 2014 13:48

1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014